New mRNA vaccine could reduce the recurrence and spread of skin cancer

NPR | By Leila Fadel

Published August 20, 2026 at 4:45 AM EDT

Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.

Leila Fadel

Leila Fadel is a host of Morning Edition, as well as NPR's morning news podcast Up First.

See stories by Leila Fadel

SUSTAIN what matters. BUILD what’s next.

With federal funding eliminated, WKAR relies more than ever on community support to sustain essential services that remain freely available to everyone in mid-Michigan. Your support helps shape what comes next for public media in our region. The best way to support WKAR is by becoming a sustaining member today or by upgrading your current gift. Support WKAR TV Here | Support WKAR Radio Here.